Exploring Components, Sensors, and Techniques for Cancer Detection via eNose Technology: A Systematic Review
Sensors · 2024
DOI: 10.3390/s24237868 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Sensors, 2024. Verfasst von Washington Ramírez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias de la Computación, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui S/N, Sangolquí 171104, Ecuador. Hauptthemen laut MEDLINE: Electronic Nose, Neoplasms, Volatile Organic Compounds. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper offers a systematic review of advancements in electronic nose technologies for early cancer detection with a particular focus on the detection and analysis of volatile organic compounds present in biomarkers such as breath, urine, saliva, and blood. Our objective is to comprehensively explore how these biomarkers can serve as early indicators of various cancers, enhancing diagnostic precision and reducing invasiveness. A total of 120 studies published between 2018 and 2023 were examined through systematic mapping and literature review methodologies, employing the PICOS (Population, Intervention, Comparison, Outcome, and Study design) methodology to guide the analysis. Of these studies, 65.83% were ranked in Q1 journals, illustrating the scientific rigor of the included research. Our review synthesizes both technical and clinical perspectives, evaluating sensor-based devices such as gas chromatography–mass spectrometry and selected ion flow tube–mass spectrometry with reported incidences of 30 and 8 studies, respectively. Key analytical techniques including Support Vector Machine, Principal Component Analysis, and Artificial Neural Networks were identified as the most prevalent, appearing in 22, 24, and 13 studies, respectively. While substantial improvements in detection accuracy and sensitivity are noted, significant challenges persist in sensor optimization, data integration, and adaptation into clinical settings. This comprehensive analysis bridges existing research gaps and lays a foundation for the development of non-invasive diagnostic devices. By refining detection technologies and advancing clinical applications, this work has the potential to transform cancer diagnostics, offering higher precision and reduced reliance on invasive procedures. Our aim is to provide a robust knowledge base for researchers at all experience levels, presenting insights on sensor capabilities, metrics, analytical methodologies, and the transformative impact of emerging electronic nose technologies in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Ciencias de la Computación, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui S/N, Sangolquí 171104, Ecuador.
- Departamento de Informática, Universidad Politécnica Salesiana, Quito 170146, Ecuador.
- Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito 170143, Ecuador.
- Facultad de Ciencias Económicas, Universidad Central del Ecuador, Quito 170521, Ecuador.
ORCID-Profile: Washington Ramírez, Eileen Ramírez, Ibeth Manzano, Doris Meza
Zitieren
APA
Ramírez, W., Pillajo, V., Ramírez, E., Manzano, I., & Meza, D. (2024). Exploring Components, Sensors, and Techniques for Cancer Detection via eNose Technology: A Systematic Review. Sensors. https://doi.org/10.3390/s24237868
Vancouver
Ramírez W, Pillajo V, Ramírez E, Manzano I, Meza D. Exploring Components, Sensors, and Techniques for Cancer Detection via eNose Technology: A Systematic Review. Sensors. 2024. doi:10.3390/s24237868
BibTeX
@article{Ramrez2024,
author = {Ramírez, Washington and Pillajo, Verónica and Ramírez, Eileen and Manzano, Ibeth and Meza, Doris},
title = {Exploring Components, Sensors, and Techniques for Cancer Detection via eNose Technology: A Systematic Review},
journal = {Sensors},
year = {2024},
doi = {10.3390/s24237868}
}
EUVIMED